AZEVAN PHARMACEUTICALS, INC.

Organization

BETHLEHEM, PA, US

Business Address
116 RESEARCH DRIVE BETHLEHEM PA 18015 610-419-1057
Mailing Address
116 RESEARCH DRIVE BETHLEHEM PA 18015
State Location
PA
State of Incorporation
DE

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Compositions and methods for treating brain injury
- Patent number 11,628,160
- Issue date Apr 18, 2023
- Azevan Pharmaceuticals, Inc.
- Michael J. Brownstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for treating neurodegenerative diseases
- Patent number 11,319,306
- Issue date May 3, 2022
- Azevan Pharmaceuticals, Inc.
- Michael J. Brownstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating post traumatic stress disorder
- Patent number 10,953,001
- Issue date Mar 23, 2021
- Azevan Pharmaceuticals, Inc.
- Michael J. Brownstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for treating neurodegenerative diseases
- Patent number 10,364,236
- Issue date Jul 30, 2019
- Azevan Pharmaceuticals, Inc.
- Michael J. Brownstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating post traumatic stress disorder
- Patent number 9,987,265
- Issue date Jun 5, 2018
- Azevan Pharmaceuticals, Inc.
- Michael J. Brownstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for treating neurodegenerative diseases
- Patent number 9,802,925
- Issue date Oct 31, 2017
- Azevan Pharmaceuticals, Inc.
- Michael J. Brownstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Beta-lactamylalkanoic acids for treating premenstrual disorders
- Patent number 9,597,314
- Issue date Mar 21, 2017
- Azevan Pharmaceuticals, Inc.
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating post traumatic stress disorder
- Patent number 9,376,424
- Issue date Jun 28, 2016
- Azevan Pharmaceuticals, Inc.
- Michael J. Brownstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
β-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
- Patent number 8,426,400
- Issue date Apr 23, 2013
- Azevan Pharmaceuticals, Inc.
- Gary A. Koppel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antag...
- Patent number 8,048,874
- Issue date Nov 1, 2011
- Azevan Pharmaceuticals, Inc.
- Gary A. Koppel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
β-lactamyl vasopressin V1a antagonists
- Patent number 7,268,125
- Issue date Sep 11, 2007
- Azevan Pharmaceuticals, Inc.
- Robert F. Bruns, Jr.
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
β-Lactamyl vasopressin V1a Antagonists
- Patent number 7,119,083
- Issue date Oct 10, 2006
- Azevan Pharmaceuticals, Inc.
- Robert F. Bruns, Jr.
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING BRAIN INJURY
- Publication number 20240115553
- Publication date Apr 11, 2024
- Azevan Pharmaceuticals, Inc.
- Michael J. BROWNSTEIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES
- Publication number 20230123729
- Publication date Apr 20, 2023
- Azevan Pharmaceuticals, Inc.
- Michael J. BROWNSTEIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING BRAIN INJURY
- Publication number 20200276167
- Publication date Sep 3, 2020
- Azevan Pharmaceuticals, Inc.
- Michael J. BROWNSTEIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES
- Publication number 20200102294
- Publication date Apr 2, 2020
- Azevan Pharmaceuticals, Inc.
- Michael J. BROWNSTEIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING POST TRAUMATIC STRESS DISORDER
- Publication number 20190099410
- Publication date Apr 4, 2019
- Azevan Pharmaceuticals, Inc.
- Michael J. BROWNSTEIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES
- Publication number 20180201608
- Publication date Jul 19, 2018
- Azevan Pharmaceuticals, Inc.
- Michael J. BROWNSTEIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES
- Publication number 20170174670
- Publication date Jun 22, 2017
- Azevan Pharmaceuticals, Inc.
- Michael J. BROWNSTEIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING POST TRAUMATIC STRESS DISORDER
- Publication number 20160339006
- Publication date Nov 24, 2016
- Azevan Pharmaceuticals, Inc.
- Michael J. BROWNSTEIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING POST TRAUMATIC STRESS DISORDER
- Publication number 20130109666
- Publication date May 2, 2013
- Azevan Pharmaceuticals, Inc.
- Michael J. Brownstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTS
- Publication number 20110059935
- Publication date Mar 10, 2011
- Azevan Pharmaceuticals, Inc.
- Robert F. Bruns, JR.
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BETA-LACTAMYLALKANOIC ACIDS FOR TREATING PREMENSTRUAL DISORDERS
- Publication number 20090170825
- Publication date Jul 2, 2009
- Azevan Pharmaceuticals, Inc.
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Beta-Lactamyl Phenylalanine, Cysteine, and Serine Vasopressin Antag...
- Publication number 20080280870
- Publication date Nov 13, 2008
- Azevan Pharmaceuticals, Inc.
- Gary A. Koppel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
{Beta}-Lactamyl vasopression V1a antagonists and methods of use
- Publication number 20080113959
- Publication date May 15, 2008
- Azevan Pharmaceuticals, Inc.
- Gary A. Koppel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
{Beta}-Lactamyl vasopression V1a antagonists and methods of use
- Publication number 20080090797
- Publication date Apr 17, 2008
- Azevan Pharmaceuticals, Inc.
- Gary A. Koppel
- C07 - ORGANIC CHEMISTRY

NIH Research Projectlast 12 months

processing...

Count: 23

Research Projects

Information Research Project
A New Drug for the Treatment of Traumatic Brain Injury
- Application id 9775815
- Award notice date May 1, 2019
Information Research Project
Tolerability of SRX246 in Huntington's Disease Patients
- Application id 9428464
- Award notice date Feb 1, 2018
Information Research Project
Tolerability of SRX246 in Huntington's Disease Patients
- Application id 9405350
- Award notice date Feb 27, 2017
Information Research Project
Tolerability of SRX246 in Huntington's Disease Patients
- Application id 9247258
- Award notice date Feb 8, 2017
Information Research Project
Tolerability of SRX246 in Huntington's Disease Patients
- Application id 9212614
- Award notice date Mar 21, 2016
Information Research Project
Tolerability of SRX246 in Huntington's Disease Patients
- Application id 8977056
- Award notice date Aug 10, 2015
Information Research Project
New Drugs for Stress-related Affective Illness
- Application id 8511824
- Award notice date Jul 3, 2013
Information Research Project
New Drugs for Stress-related Affective Illness
- Application id 8300805
- Award notice date Jul 16, 2012
Information Research Project
New Drugs for Stress-related Affective Illness
- Application id 8334918
- Award notice date Sep 20, 2011
Information Research Project
New Drugs for Stress-related Affective Illness
- Application id 8249249
- Award notice date Jul 13, 2011
Information Research Project
Screening New Therapeutics for the Treatment of Post Traumatic Stre...
- Application id 8126147
- Award notice date May 24, 2011
Information Research Project
New Drugs for Stress-related Affective Illness
- Application id 7909010
- Award notice date May 1, 2010
Information Research Project
A Potential New Drug for Depression
- Application id 7824744
- Award notice date Sep 30, 2009
Information Research Project
A Potential New Drug for Depression
- Application id 7682306
- Award notice date Aug 11, 2009
Information Research Project
A Potential New Drug for Depression
- Application id 7490578
- Award notice date Aug 30, 2008
Information Research Project
A Potential New Drug for Depression
- Application id 7328280
- Award notice date Aug 29, 2007
Information Research Project
A New Drug for Depression
- Application id 7143533
- Award notice date Aug 21, 2006
Information Research Project
A New Drug for Depression
- Application id 7125598
- Award notice date Nov 7, 2005
Information Research Project
A New Drug for Depression
- Application id 6833384
- Award notice date Aug 31, 2004
Information Research Project
Treating Self-Abuse in Autism and Mental Retardation
- Application id 6603570
- Award notice date Jun 18, 2003
Information Research Project
Treating Self-Abuse in Autism and Mental Retardation
- Application id 6485783
- Award notice date Jul 1, 2002
Information Research Project
A New Drug for Depression
- Application id 6444275
- Award notice date Feb 13, 2002
Information Research Project
TREATING SELF-ABUSE IN AUTISM AND MENTAL RETARDATION
- Application id 2776073
- Award notice date Apr 14, 2000

AZEVAN PHARMACEUTICALS, INC.

Organization

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Compositions and methods for treating brain injury

Compositions and methods for treating neurodegenerative diseases

Methods for treating post traumatic stress disorder

Compositions and methods for treating neurodegenerative diseases

Methods for treating post traumatic stress disorder

Compositions and methods for treating neurodegenerative diseases

Beta-lactamylalkanoic acids for treating premenstrual disorders

Methods for treating post traumatic stress disorder

β-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists

Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antag...

β-lactamyl vasopressin V1a antagonists

β-Lactamyl vasopressin V1a Antagonists

Patents Applicationslast 30 patents

COMPOSITIONS AND METHODS FOR TREATING BRAIN INJURY

COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES

COMPOSITIONS AND METHODS FOR TREATING BRAIN INJURY

COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES

METHODS FOR TREATING POST TRAUMATIC STRESS DISORDER

COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES

COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES

METHODS FOR TREATING POST TRAUMATIC STRESS DISORDER

METHODS FOR TREATING POST TRAUMATIC STRESS DISORDER

Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTS

BETA-LACTAMYLALKANOIC ACIDS FOR TREATING PREMENSTRUAL DISORDERS

Beta-Lactamyl Phenylalanine, Cysteine, and Serine Vasopressin Antag...

{Beta}-Lactamyl vasopression V1a antagonists and methods of use

{Beta}-Lactamyl vasopression V1a antagonists and methods of use

NIH Research Projectlast 12 months

Research Projects

A New Drug for the Treatment of Traumatic Brain Injury

Tolerability of SRX246 in Huntington's Disease Patients

Tolerability of SRX246 in Huntington's Disease Patients

Tolerability of SRX246 in Huntington's Disease Patients

Tolerability of SRX246 in Huntington's Disease Patients

Tolerability of SRX246 in Huntington's Disease Patients

New Drugs for Stress-related Affective Illness

New Drugs for Stress-related Affective Illness

New Drugs for Stress-related Affective Illness

New Drugs for Stress-related Affective Illness

Screening New Therapeutics for the Treatment of Post Traumatic Stre...

New Drugs for Stress-related Affective Illness

A Potential New Drug for Depression

A Potential New Drug for Depression

A Potential New Drug for Depression

A Potential New Drug for Depression

A New Drug for Depression

A New Drug for Depression

A New Drug for Depression

Treating Self-Abuse in Autism and Mental Retardation

Treating Self-Abuse in Autism and Mental Retardation

A New Drug for Depression

TREATING SELF-ABUSE IN AUTISM AND MENTAL RETARDATION